🔗 Permalink

Inventor profile of:

Robert HUBER

City:

Germering

Country:

Germany

Published Applications:

Last publication date:

2012-07-26

Top Assignees for applications by Robert HUBER

The entities that hold a legal rights for patent applications filed by inventor HUBER Robert:

Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V. 3 Munich, Germany
Wilex Biotechnology GmbH 2 Munich, Germany
Bayer CropScience AG 1 Monheim, Germany
Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V. 1 , Germany
Max-Planck-Gessellschaft zur Forderung der Wissenschaften E.V. 1 Munich, Germany
MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN e.V. 1 Muenchen, Germany

Recent patent applications by HUBER Robert

Robert HUBER from Germering, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2012-07-26

US20120190821A1

Chemistry; metallurgy

Recombinant soluble FC receptors

#2 | 2009-11-26

US20090292113A1

Chemistry; metallurgy

Recombinant soluble Fc receptors

#3 | 2009-10-13

US10621866

Methods for identifying inhibitors of the 20S and 26S proteasome

#4 | 2009-05-07

US20090117662A1

Chemistry; metallurgy

Mutants of IGF Binding Proteins and Methods of Production of Antagonists Thereof

#5 | 2008-09-04

US20080214459A1

Human necessities

Pharmaceutical composition containing sFcyRIIb

#6 | 2007-09-06

US20070207163A1

Chemistry; metallurgy

Recombinant soluble Fc receptors

#7 | 2006-07-11

US9856933

Recombinant soluble Fc receptors

#8 | 2005-11-24

US20050260727A1

Chemistry; metallurgy

Crystal structure of the mitochondrial protoporphyrinogen IX oxidase

#9 | 2005-06-02

US20050119348A1

Chemistry; metallurgy

Highly selective inhibitors of the urokinase plasminogen activator

#10 | 2005-02-10

US20050033035A1

Chemistry; metallurgy

Mutants of igf binding proteins and methods of production of antagonists thereof

#11 | 2005-01-11

US10239074

Highly selective inhibitors of the urokinase plasminogen activator

#12 | 2005-01-06

US20050002924A1

Human necessities

Pharmaceutical composition containing sFcgammaR IIb or sFcgammaR III

InventorID:

3224088 ⎘